Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Radiation Dose Hypofractionation × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Prostatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Prostate Adenocarcinoma 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Meningioma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Carcinoma In Situ 1 Brain Neoplasms 1 Advanced Refractory Solid Tumors 1

Interventions

Temozolomide 8 Vincristine 7 Irinotecan 6 Cyclophosphamide 6 Etoposide 5 Specimen Handling 4 Ifosfamide 4 Doxorubicin 4 regorafenib 3 Radiotherapy 3 Radiation 3 Magnetic Resonance Spectroscopy 3 ivosidenib 2 fludarabine 2 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 X-Rays 2 Topotecan 2 Surgical Procedures, Operative 2 Sirolimus 2 Phantoms, Imaging 2 PM 01183 2 Melphalan 2 Eflornithine 2 Congresses as Topic 2 Biopsy 2 ulixertinib 1 tipifarnib 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07188532 2026-01-23

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡